Nanjing Well Pharmaceutical Group Co (SHSE:603351) 3-Year Book Growth Rate : 7.20% (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Nanjing Well Pharmaceutical Group Co 3-Year Book Growth Rate?

Nanjing Well Pharmaceutical Group Co's Book Value per Share for the quarter that ended in Mar. 2025 was ¥12.84.

During the past 12 months, Nanjing Well Pharmaceutical Group Co's average Book Value per Share Growth Rate was 7.30% per year. During the past 3 years, the average Book Value per Share Growth Rate was 7.20% per year. During the past 5 years, the average Book Value per Share Growth Rate was 5.70% per year. During the past 10 years, the average Book Value per Share Growth Rate was 12.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 11 years, the highest 3-Year average Book Value per Share Growth Rate of Nanjing Well Pharmaceutical Group Co was 28.10% per year. The lowest was 4.80% per year. And the median was 8.05% per year.

Competitive Comparison of Nanjing Well Pharmaceutical Group Co's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Nanjing Well Pharmaceutical Group Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanjing Well Pharmaceutical Group Co's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nanjing Well Pharmaceutical Group Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Nanjing Well Pharmaceutical Group Co's 3-Year Book Growth Rate falls into.

Save Embed

;

Save Embed

;

Nanjing Well Pharmaceutical Group Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Nanjing Well Pharmaceutical Group Co (SHSE:603351) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Nanjing Well Pharmaceutical Group Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Nanjing Well Pharmaceutical Group Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing Well Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Well Pharmaceutical Group Co Ltd (SHSE:603351) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

N/A

Address

No. 99, Changfeng Hexi Road, Nanjing Chemical Industry Park, Jiangsu Province, Nanjing, CHN, 210000

Website

http://www.well-js.com

Nanjing Well Pharmaceutical Group Co Ltd is engaged in research and development, production and sales of pharmaceutical auxiliary materials and synthetic lubricating base oil and other products. The company uses a variety of pharmaceutical dosage forms such as injection, oral administration and external use to guarantee the molding, effectiveness, stability and safety of pharmaceutical dosage forms.

Executives

Zou Jian Guo	senior management
Wang Fu Qiu	Directors, senior managers
Wu Rong Wen	Supervisors

Nanjing Well Pharmaceutical Group Co Headlines

No Headlines